Search for: "Johnson v. GlaxoSmithKline" Results 1 - 20 of 48
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2024, 10:55 am by Evangelina Cantu
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
29 Jan 2024, 4:35 pm
v=BxL9DRdk6Xc   New Animation: End Hare Coursing In a world where compassion and empathy should be our guiding principles, it is disheartening to discover that some individuals derive enjoyment and profit from the suffering of innocent creatures. [read post]
16 Sep 2018, 10:54 am by Schachtman
Johnson & Johnson, No. 09-cv-04124, 2014 WL 2943572, at *5 (N.D. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Civil Procdedure – Final Judgment: Johnson & Johnson Vision Care, Inc. v. [read post]
11 Jun 2013, 10:50 am by John J. Sullivan
 But the roles were reversed in the diversity jurisdiction dispute addressed by the Third Circuit in Johnson v. [read post]
26 Jul 2012, 5:00 am by Kimberly A. Kralowec
  (See Bridgeford, supra, 202 Cal.App.4th at p. 1044; see also Johnson v. [read post]
10 Apr 2012, 5:00 am by Kimberly A. Kralowec
GlaxoSmithKline, Inc. (2008) 166 Cal.App.4th 1497, 1510-1513 & fn. 8 (Johnson) [assuming the point while expressing reservations].) [read post]